Michael S. Ip, MD
Show Description +
Michael S. Ip, MD, shares data from the phase 1/2a OpRegen study in which human embryonic stem cell–derived retinal pigment epithelium cells are transplanted subretinally in patients with geographic atrophy.
Posted: 11/17/2021
Michael S. Ip, MD
Michael S. Ip, MD, shares data from the phase 1/2a OpRegen study in which human embryonic stem cell–derived retinal pigment epithelium cells are transplanted subretinally in patients with geographic atrophy.
Posted: 11/17/2021
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2021.
Please log in to leave a comment.